Organigram Global Inc. is a cannabis company.[2][3] The business has a facility in Moncton.[4]
Business
Organigram is a Canadian company that produces and sells cannabis and cannabis-derived products, including dried flower, pre-rolls, vapes, concentrates, oils, and edibles, for both the adult-use and medical markets.[5][6]
The company generates revenue through sales to provincial cannabis boards, direct sales to medical patients, and exports and partnerships in certain international markets.[6]
History
On March 24th, 2025, Organigram investors approved rebranding from Organigram Holdings to Organigram Global.[7][8]
In 2023, the company reported a quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million and margins improved.[4]
In November 2025, the company announced that James Yamanaka, a former executive at British American Tobacco, was being appointed CEO effective around January 15, 2026, and that he would also join the company’s board.[9]
See also
External links
References
- Organigram MD&A 2024 December 18, 2024^
- Dan Ahrens. Investing in Cannabis: The Next Great Investment Opportunity John Wiley & Sons, 2023-04-04^
- Stephen Satoshi. Cryptocurrency for Beginners: The Newbie Friendly Guide for Making Money with Bitcoin and Altcoins in 2018 and Beyond 2018-07-31^
- Cannabis company Organigram reports Q1 profit as revenue and margins improve Toronto Star, 2023-01-12, retrieved 2025-04-08^
- https://finance.yahoo.com/quote/OGI/profile/^
- OrganiGram Holdings Inc. (OGI): History, Ownership, Mission, How It Works & Makes Money AI-Powered Discounted Cash Flow Editable Templates, 2025-11-22, retrieved 2025-12-17^
- Margaret Jackson. Canadian cannabis producer rebrands as Organigram Global MJBizDaily, 2025-03-26, retrieved 2025-04-21^
- Dulan Lokuwithana. Organigram investors approve name change Seeking Alpha, 2025-03-25^
- https://www.businesswire.com/news/home/20251125699142/en/Organigram-Announces-Appointment-of-Chief-Executive-Officer^